" class="no-js "lang="en-US"> Sectra - Medtech Alert
Tuesday, August 19, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Sectra | Pharmtech Focus

Sectra

About Sectra

Sectra

Driven by knowledge and passion, our vision is to contribute to a healthier and safer society. Sectra successfully develops and sells cutting-edge solutions in the expanding niche segments of medical IT and cybersecurity. The Sectra Group has some 800 employees worldwide.

Related Story

Companies

 Canadian North York General Hospital Chooses Enterprise Imaging Solution from Sectra to Improve Radiology Workflows | Pharmtech Focus

Canadian North York General Hospital Chooses Enterprise Imaging Solution from Sectra to Improve Radiology Workflows

April 13 2022

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a contract with North […]